CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
5.38
0.00 (0.00%)
At close: Sep 26, 2025, 3:59 PM
5.02
-6.69%
After-hours: Sep 26, 2025, 07:55 PM EDT
0.00% (1D)
| Bid | 5.02 |
| Market Cap | 6.48M |
| Revenue (ttm) | 1.16M |
| Net Income (ttm) | -13.51M |
| EPS (ttm) | -363.01 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.07 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.37 |
| Volume | 260,499 |
| Avg. Volume (20D) | 150,538 |
| Open | 5.39 |
| Previous Close | 5.38 |
| Day's Range | 5.28 - 5.60 |
| 52-Week Range | 4.27 - 896.00 |
| Beta | 0.50 |
| Ex-Dividend Date | n/a |
About CERO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CERO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CERO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-20.95%
CERo Therapeutics Holdings shares are trading lowe...
Unlock content with
Pro Subscription
3 months ago
+188.65%
CERo Therapeutics shares are trading higher after the company received FDA Orphan Drug Designation for CER-1236 for the treatment of acute myeloid leukemia.
